7-2

Phosphoinositide 3-kinase (PI 3-kinase) pathway: This is crucial for mediating responses to various extracellular signals and plays a pivotal role in cellular growth and survival.
Ras pathway: This pathway is intimately involved in cell growth, differentiation, and survival, especially in relation to oncogenic signaling.

Roles: The PI 3-kinase pathway is integral to multiple cellular processes, notably in cell proliferation, differentiation, inhibition of programmed cell death (apoptosis), and regulation of metabolic pathways such as glucose metabolism and glycogen synthesis.
Activation: Triggered by a range of receptors, including but not limited to receptor tyrosine kinases, the PI 3-kinase pathway responds dynamically to signals such as hormones, growth factors, and neurotransmitters (e.g., insulin, EGF).

Insulin Overview: Insulin is a peptide hormone secreted chiefly by the pancreatic beta cells in response to elevated blood glucose levels post-meal.
- It facilitates the translocation of glucose transporters (GLUT4) to the cell surface, which is especially prominent in adipocytes (fat cells) and myocytes (muscle cells). This action significantly enhances glucose uptake, thereby lowering blood glucose levels.
Complexity of Signaling: The insulin signaling pathway contains various branches leading to distinct cellular effects, highlighting the hormone's multifaceted role in metabolism and cellular homeostasis.

Insulin consists of two polypeptide chains: an alpha (α) chain and a beta (β) chain, which are linked by two interchain disulfide bonds while one intrachain disulfide bond links residues within the beta chain, providing its structural integrity.

Monomeric Form: The insulin receptor exists as a homodimer, composed of two α chains located extracellularly and two β chains that span the cell membrane and possess intrinsic kinase activity.
Inactive State: In its inactive form, the receptor's activation loop obstructs the ATP-binding site, rendering the kinase domain inert prior to insulin binding.

Upon insulin binding, the receptor undergoes a conformational shift from an inverted 'V' to a 'T' shape. This realignment facilitates cross-phosphorylation of tyrosine residues within the kinase domains, activating the receptor's intrinsic kinase activity.

Following insulin binding, the activation loops swing out, creating an open active site that enables the kinase to become functional. This mechanism is essential for amplifying the signaling cascade downstream.

The pathway involves phosphorylation cascades that activate a series of downstream kinases:
- Insulin + Insulin receptor → cross-phosphorylation → activation of IRS-1 (Insulin Receptor Substrate 1) —> localised phosphoinositde 3 kinase→ PIP3 formation → activation of PDK1 → Akt (PKB) activation, which regulates metabolic processes and cell survival.

PIP3: Phosphatidylinositol (3,4,5)-trisphosphate, a secondary messenger generated from phosphatidylinositol bisphosphate by the enzymatic action of PI3K, is vital for recruiting and activating PDK1 and subsequently Akt (PKB) within the signaling cascade.
IRS: Insulin receptor substrates, particularly IRS-1, are essential adapters that orchestrate the signaling cascade by interacting with various downstream effectors and transducing the insulin signal into the cell nucleus to modulate gene expression. pleckstrin homology domain = amino-terminal part of IRSs that binds phosphoinositide. Each IRS protein contains four Tyr-X-X-Met sequences.
SH2 DOMAIN: A protein domain that mediates specific binding to phosphotyrosine-containing sequences on IRS proteins, facilitating recruitment of downstream signaling partners, such as phospholipase C-gamma and various kinases to propagate the insulin signaling pathway.
PH domain: The pleckstrin homology (PH) domain is a protein domain that plays a crucial role in the localization of signaling proteins to the plasma membrane by binding to phosphoinositides, thereby facilitating the interaction of these proteins with other components of the insulin signaling pathway.
PI3K: Phosphoinositide 3-kinase, a key enzyme that phosphorylates PIP2 to form PIP3, playing a crucial role in the insulin signaling pathway by facilitating Akt activation.

The Ras pathway is activated primarily by growth factor-specific receptors and is a pivotal player in mediating mitogenic signals.
Key components of the pathway include Raf, MEK, and ERK, collectively known as mitogen-activated protein kinases (MAPKs). This cascade plays a critical role in controlling gene expression, cellular proliferation, and differentiation.
Activation typically occurs in response to epidermal growth factor (EGF) and results in a series of cellular effects including the modulation of transcription factors that govern the expression of genes critical for cell cycle progression and survival.
EGF+EGF receptor—>phosphorylated receptor—>EGF receptor sos complex—>Ras activation—>Raf activation—>MEK activation—>ERK activation—>gene expression modulation.

The binding of EGF initiates the dimerization of its receptor (EGFR), bringing the kinase domains in proximity, which leads to the phosphorylation of specific tyrosine residues—this is a crucial step in the activation of downstream signaling pathways.

Phosphorylation of the EGF receptor generates docking sites for the adaptor protein Grb2, which recruits Sos (Son of Sevenless), leading to the activation of Ras through GDP-GTP exchange—this action is fundamental to the propagation of signals that drive cell growth and differentiation.

Signal termination mechanisms actively regulate pathways to prevent uncontrolled cell proliferation. Phosphatases remove phosphate groups, reversing activation. Moreover, Ras possesses intrinsic GTPase activity which hydrolyzes GTP to GDP, terminating the signal, with the assistance of GTPase-activating proteins (GAPs) enhancing this process.

Defects in signaling proteins, particularly mutations in genes encoding for Ras, can lead to unregulated cell growth, which is a hallmark of cancerous transformations. Mutations can convert proto-oncogenes into oncogenes, resulting in malignant cellular behavior.
It is vital to understand the distinction between oncogenes, which promote cancer development, proto-oncogenes, which regulate normal cell functions, and tumor-suppressor genes, which inhibit cell division and prevent tumor formation.

Monoclonal antibodies, such as Cetuximab and Trastuzumab, have been designed to target overexpressed receptors (like EGFR) found in certain cancer tissues, inhibiting their activity and preventing further growth signals.
Targeted therapy, exemplified by specific kinase inhibitors like Imatinib (Gleevec), selectively blocks tumor-specific signaling pathways, showcasing a evolving approach in cancer treatment that minimizes effects on normal tissues.

The action of protein kinases is fundamental for the versatility and precision of signaling processes in cells. Second messengers amplify cellular signals, whereas specialized domains, such as SH2 (Src Homology 2) and PH (Pleckstrin Homology), facilitate specific protein-protein interactions that are critical for maintaining signaling fidelity and efficiency.